Paclitaxel and weekly 24-hour infusion of 5-fluorouracil folinic acid in advanced gastric cancer

被引：0
|
作者：
Bokemeyer, C
Hartmann, JT
Lampe, CS
Clemens, MR
Quietzsch, D
Forkmann, L
Kanz, L
机构：
[1] Univ Tubingen, Med Ctr 2, Dept Hematol Oncol Immunol, D-72076 Tubingen, Germany
[2] Krankenanstalt Mutterhaus, Dept Internal Med, Trier, Germany
[3] Stadt Kliniken, Dept Internal Med, Chemnitz, Germany
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S96 / S100
页数：5
相关论文
共 50 条
  • [41] Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: Lack of activity in advanced colorectal cancer
    Natoli, C
    Scognamiglio, MT
    Martino, MT
    Irtelli, L
    De Tursi, M
    Cianchetti, E
    Mascitelli, E
    Tinari, N
    Iacobelli, S
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1253 - 1256
  • [42] Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer?: A phase II study
    Hartmann, JT
    Köhne, CH
    Schmoll, HJ
    Daikeler, T
    Kanz, L
    Bokemeyer, C
    ONCOLOGY, 1998, 55 (04) : 320 - 325
  • [43] Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer
    Eckel, F
    Lersch, C
    Lippl, F
    Assmann, G
    Schulte-Frohlinde, E
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (03) : 295 - 300
  • [44] A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
    Chen, LT
    Liu, TW
    Wu, CW
    Chung, TR
    Shiah, HS
    Jan, CM
    Liu, JM
    Whang-Peng, J
    Chang, JY
    ONCOLOGY, 2002, 63 (03) : 239 - 247
  • [45] Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC)
    Wein, Axel
    Siebler, Juergen
    Wolff, Kerstin
    Ostermeier, Nicola
    Busse, Dagmar
    Hagel, Alexander
    Koch, Franz
    Merx, Kirsten
    Neurath, Markus Friedrich
    Hofheinz, Ralf-Dieter
    ANTICANCER RESEARCH, 2017, 37 (07) : 3771 - 3779
  • [46] Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer
    Wilke, H
    Klaassen, U
    Achterrath, W
    Losch, M
    Vanhoefer, U
    Hayungs, J
    Harstrick, A
    Stahl, M
    Eberhardt, W
    Becher, R
    Seeber, S
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 55 - 58
  • [47] Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: A multicentre phase II trial
    Kuhfahl, J
    Steinbrecher, C
    Wagner, T
    Wagner, H
    Fritze, D
    Link, H
    Schulte, F
    Pichlmeier, U
    Kreuser, ED
    ONKOLOGIE, 2004, 27 (05): : 449 - 454
  • [48] Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusion
    Limacher, JM
    Duclos, B
    Wihlm, J
    Leveque, D
    Dufour, P
    Eichler, F
    Keiling, R
    Bergerat, JP
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 945 - 945
  • [49] A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer
    Gu, Yanhong
    Shu, Yongqian
    Xu, Qiang
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (04) : 293 - 296
  • [50] Chronomodulated infusion of irinotecan, 5-fluorouracil and folinic acid and hematological toxicity in patients with advanced gastrointestinal cancer
    Merkel, U
    Farker, K
    Wedding, U
    Hippius, M
    Höffken, K
    Hoffmann, A
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A45 - A45
12345